EP 88: Precision oncology: how Next Generation Sequencing (NGS) is powering care today and the treatments of the future with Christine Ward (Takeda) and Geoff Oxnard (Foundation Medicine)
- Author
- Sano Genetics
- Published
- Thu 10 Nov 2022
- Episode Link
- https://podcasters.spotify.com/pod/show/sano-genetics/episodes/EP-88-Precision-oncology-how-Next-Generation-Sequencing-NGS-is-powering-care-today-and-the-treatments-of-the-future-with-Christine-Ward-Takeda-and-Geoff-Oxnard-Foundation-Medicine-e2u3jie
In this episode, guests Christine Ward, VP and Head of Oncology and Cell Therapy Precision & Translational Medicine at Takeda and Geoff Oxnard, Thoracic Oncologist and VP of Foundation Medicine talk to Patrick about Next Generation Sequencing (NGS) in precision oncology. Also covered are the impact of large-scale genetic datasets on patient diagnosis, data consortiums enabling pioneering discoveries, and the recent partnership between Takeda and Foundation Medicine.
